Spark Investment Management’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-13,500
Closed -$52K 840
2017
Q4
$52K Buy
+13,500
New +$73.5K ﹤0.01% 660
2017
Q1
Sell
-106,700
Closed -$586K 986
2016
Q4
$586K Buy
106,700
+75,600
+243% +$534K 0.05% 450
2016
Q3
$235K Sell
31,100
-46,400
-60% -$339K 0.02% 639
2016
Q2
$632K Buy
77,500
+40,600
+110% +$506K 0.06% 411
2016
Q1
$479K Buy
+36,900
New +$426K 0.05% 445
2015
Q3
Sell
-11,400
Closed -$235K 858
2015
Q2
$235K Sell
11,400
-5,200
-31% -$123K 0.03% 497
2015
Q1
$349K Buy
16,600
+300
+2% +$7.83K 0.05% 444
2014
Q4
$498K Sell
16,300
-2,600
-14% -$72.3K 0.08% 320
2014
Q3
$329K Buy
+18,900
New +$239K 0.05% 431

Other funds holding IMDZ

Spark Investment Management's IMDZ Position: Q1 2018 in Review

Spark Investment Management sold out of Immune Design Corp. (IMDZ) in Q1 2018, closing a stake of 13,500 shares — an estimated $52K sold.

Spark Investment Management first reported a position in IMDZ in Q3 2014 and held it in 9 quarters. The position peaked at $632K in Q2 2016. 72 funds tracked by Wall St. Rank hold IMDZ as of Q1 2018.

  • Spark Investment Management reported no remaining Immune Design Corp. position as of Q1 2018 after selling out during the quarter.
  • Spark Investment Management sold 13,500 Immune Design Corp. shares in Q1 2018, an estimated $52K.
  • Spark Investment Management first reported a position in Immune Design Corp. in Q3 2014 and held it in 9 quarters.
  • Spark Investment Management's Immune Design Corp. position peaked at $632K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2018.

Based on Spark Investment Management's 13F filing for Q1 2018, filed 10 May 2018.